Please select from the following list of abstracts, representing the presentations given in Venice 2010 (IWWM-6) Session 12:
Development of WM cell lines. Novak (USA)
Assessment of cytokines and chemokines in patients with WM. Lewicki (Canada)
Quantification of IgM kappa and IgM lambda in WM. Koulieris (Greece)
SM-IgC as response criteria in WM. Guidez (France)
Factors predicting malignant evolution of IgM-MGUS and IgM related disorders. Greco (Italy)
Gene expression of malignant and micro-environment cells from WM patients. Trojani (Italy)
Sp1 trans-activation in WM. Fulciniti (USA)
Metalloprotease inhibitors and CD27 in WM. Liu (USA)
NVP-BEZ235 exerts anti-tumor activity in WM. Sacco (USA)
Clinical impact of sFLCs or FLCR on WM. Maltezas (Greece)
Rituximab, Fludarabine and Cyclophosphamide in WM. Compain (France)
Induced resistance to Bortezomib and its association with BCL-2 up-regulation. Chitta (USA)
Role of hypoxia in the dissemination of WM. Azab (USA)
Impact of advanced age in WM at diagnosis. Ricci (Italy)
Anti-MAG neuropathy. Hospital (France)
*** Special Guest Lectures ***
Update in Indolent NHL: Paradigm for WM. Vitolo (Italy)
Update in Multiple Myeloma Therapy: Paradigm for WM. Boccadoro (Italy)
